Abstract:Background: Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency (HMGCS2D) is a rare autosomal recessive metabolic disorder caused by mutations of the HMGCS2 gene. To date, no more than 60 patients have been reported throughout the world.Purpose: To analyze the clinical, biochemical, molecular, and outcome features of HMGCS2D in a case series of 10 new Chinese patients.Methods: This retrospective study includes 10 Chinese patients diagnosed with HMGCS2D. We collected and analyzed clinical data for all patients. We also reviewed clinical data for 39 cases that had been reported previously.Results: All of our patients had experienced their first metabolic crisis before 12 months old. The most common clinical manifestations were anorexia, dyspnea, and disturbance of consciousness (10/10), followed by vomiting (8/10), fever (7/10), cough (4/10), diarrhea, and seizures (3/10). Each patient (10/10) had a different degree of hepatomegaly and increased aminotransferase, severe metabolic acidosis, and hypofibrinogenemia. 9 patients presented with severe hypoglycemia and weak positives on qualitative tests of urinary ketone body. Patient 3 was the only one without hypoglycemia. Five patients had hypocalcemia, five patients had hyperammonemia, four patients had hyperuricemia, and three had hypertriglyceridemia. During the metabolic acidosis episode, we observed high dicarboxylic acid values in urine, and the elevated ratio of blood acetylcarnitine to free carnitine may have been an additional biochemical signature. However, all returned to normal during the interictal interval. Molecular analysis identified 15 variants in the HMGCS2 gene, of which 10 were novel (c.220G>A/p.E74K, c.407A>G/p.D136G, c.422T>A/p.V141D, c.719A>C/p.D240A, c.821G>A/p.R274H, c.39dupA/p.L14Tfs*59, c.1394delA/p.N465Tfs*10, c.788delT/p.L263Cfs*36, c.717T>G/p.Y239*, and c.1017-2A>G). Combining these with previous cases, the known mutation c.1201G>T/p.E401* has been found in 6/40 (15.0%) of mutated alleles in 21 Chinese patients from 20 families, while none have been found in other populations. We found that patients with biallelic truncation mutation appeared to show a more severe clinical condition through a literature review.Conclusion: This study analyzed the phenotypic and genetic features of HMGCS2D in a Chinese case series. We also expanded the HMGCS2 mutational spectrum with 10 novel variants. The c.1201G>T/p.E401* mutation was the most frequent, representing 15.0% of the mutated alleles in reported unrelated Chinese patients, and thus, it may be a hot spot mutation.

A Fatal Case of Mitochondrial DNA Depletion Syndrome with Novel Compound Heterozygous Variants in the Deoxyguanosine Kinase Gene.

[Clinical features and DGUOK mutations of an infant with mitochondrial DNA depletion syndrome]

[Clinical and Genetic Analyses of a Family with Atypical Nonketotic Hyperglycinemia Caused by Compound Heterozygous Mutations in the GLDC Gene].

[Dguok-Related Mitochondrial DNA Depletion Syndrome: a Case Report and Literature Review].

A Deafness-Associated Mitochondrial DNA Mutation Altered the Trnaser(ucn) Metabolism and Mitochondrial Function.

Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease

DNA2 Mutation Causing Multisystemic Disorder with Impaired Mitochondrial DNA Maintenance

[Analysis of GFM1 Gene Mutations in a Family with Combined Oxidative Phosphorylation Deficiency 1].

Two novel POLG mutations causing hepatic mitochondrial DNA depletion with recurrent hypoketotic hypoglycaemia and fatal liver dysfunction

Novel compound heterozygous SUCLG1 variants may contribute to mitochondria DNA depletion syndrome-9

Mitochondrial deoxyguanosine kinase is required for female fertility in mice

[Phenotype and genotype of twelve Chinese children with mitochondrial DNA depletion syndromes]

A Case of SUCLG1-related Infantile Encephalomyopathy Mitochondrial DNA Depletion Syndrome

Two novel SUCLA2 variants cause mitochondrial DNA depletion syndrome, type 5 in two siblings

A Family Segregating Lethal Primary Coenzyme Q10 Deficiency Due to Two Novel COQ6 Variants

Quantitative evaluation of the mitochondrial DNA depletion syndrome

Mitochondrial depletion syndrome type 3: the Lebanese variant

Clinical, Biochemical, Molecular, and Outcome Features of Mitochondrial 3-Hydroxy-3-methylglutaryl-coa Synthase Deficiency in 10 Chinese Patients

Genome sequencing reveals a novel genetic mechanism underlying dihydropyrimidine dehydrogenase deficiency: A novel missense variant c.1700G>A and a large intragenic inversion in DPYD spanning intron 8 to intron 12

Exercise Intolerance and Developmental Delay Associated with a Novel Mitochondrial ND5 Mutation.

Role and Mechanism of Mitochondrial Deoxyguanosine Kinase in Lung Cancer Tumorigenesis